Washington, United States,
08048034981
MyHep All Tablet
City Drug House Exporters | Hepatitis Medicines Supplier to Washington, USA, INDIA

City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.

MyHep All is a prescription antiviral medication used to treat chronic Hepatitis C virus (HCV) infection in adults and children. It combines two direct-acting antiviral agents that stop the virus from multiplying, eventually clearing the infection from the body.

Mechanism of Action:

Sofosbuvir: A nucleotide analog NS5B polymerase inhibitor. It acts as a defective building block, incorporating itself into the Hepatitis C viral RNA to terminate the replication process.

Velpatasvir: An NS5A inhibitor. It targets and binds to the viral phosphoprotein NS5A, which is crucial for viral replication and the assembly of new virions.

Dosage & Administration

Standard Adult Dose: One tablet (400 mg/100 mg) taken orally once daily.

Food: Can be taken with or without food.

Duration: Treatment typically lasts 12 to 24 weeks, depending on the viral genotype and prior treatment history.

Cautions & Side Effects :

Side Effects: Fatigue, headache, nausea, diarrhea, and insomnia.

Key Warnings: Must not be used if you have a current or previous Hepatitis B infection (can cause reactivation). Requires monitoring of liver and kidney function.

Drug Interactions: Can dangerously interact with certain medications, such as amiodarone (heart medication), rifampin (tuberculosis), and St. John's wort.

City Drug House Exporters provides:

Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics

Contact for More Information :
📞 Contact City drug House Exporters from India

🌐 Websites:
https://www.citydrugexporters.com

📧 Email: citydrug123@gmail.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 9975390171
May 23rd, 2026 2:42 PM

Keywords